/Not for distribution to U.S. news wire services or for dissemination in the United States/ VANCOUVER, British Columbia, Aug. 02,…
Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and…
LONG BEACH, Calif., Aug. 2, 2024 /PRNewswire/ -- Anivive Lifesciences Inc, a One Health technology company today announced that the National…
TEMPE, Ariz. and MEXICO CITY, Aug. 2, 2024 /PRNewswire/ -- To support the growing needs of the global supply chain…
Toronto, Ontario--(Newsfile Corp. - August 2, 2024) - Safe Supply Streaming Corp. (CSE: SPLY) is pleased to announce significant updates…
KANSAS CITY, Mo., Aug. 2, 2024 /PRNewswire/ -- CRB, a leading international provider of engineering, architecture, construction and consulting services…
TAMPA, Fla., Aug. 2, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company, operates as…
CHICAGO, IL / ACCESSWIRE / August 2, 2024 / The American Society for Transplantation and Cellular Therapy (ASTCT®) applauds the…
KARE PharmTech: Empowering Physicians, Pharmacists, and Patients to Improve Patient CareTAMPA, FL / ACCESSWIRE / August 2, 2024 / KARE…
LINCOLN, NE / ACCESSWIRE / August 2, 2024 / Neighborhood LTC Pharmacy, a leader in pharmacy services for individuals with…